Feb. 18 at 10:22 PM
$CBWTF Hugo, you don’t buy failed companies, especially Ayurcann. If you do you’re more of an idiot than most believed!
Ayurcann Financial Position: As of June 30, 2025, the company had an accumulated deficit of nearly
$17.9 million and a working capital deficit of almost
$4.9 million. It’s worse now! The deficit is 30% higher than the asset value of the whole company. They’re also in Tax hell that Auxly would have to eat a chunk of. Oh and it’s not just the initial investor/company cash outlay, there’s ongoing operating expenses that would eat in your Auxly’s bottom line, making the investor ROI even worse.
As of late 2025, Ayurcann announced it would voluntarily delist from the OTCQB to focus on its Canadian Securities Exchange (CSE) listing.